Familial Hypercholesterolemia
📧 Sign up to get email alerts when something new happens for Familial Hypercholesterolemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-01-27FDA Approved: SIMVASTATIN — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for simvastatin from Accord Healthcare, Inc., finalizing the regulatory action for this generic prod…
-
FDA approval · 2012-12-30FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals' supplemental application for pravastatin sodium, a generic statin, reflecting an approved update for this…
-
FDA approval · 2012-11-30FDA Approved: LIPITOR — Supplemental Application (Viatris Specialty LLC)
FDA approved Lipitor (atorvastatin calcium) under a supplemental application submitted by Viatris Specialty LLC.
-
FDA approval · 2012-11-28FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC under ANDA077691. The approval expands the availab…
-
FDA approval · 2012-11-27FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for atorvastatin calcium from Dr. Reddy's Laboratories Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-11-15FDA Approved: ZOCOR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for ZOCOR (simvastatin) filed by Organon LLC.
-
FDA approval · 2012-09-28FDA Approved: SIMVASTATIN — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Simvastatin from Accord Healthcare, Inc., updating the approval status under the ANDA.
-
FDA approval · 2012-07-20FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (CIPLA USA INC.)
FDA approved a supplemental application for Pravastatin Sodium by Cipla USA Inc., marking an approved change to the product's approval.
-
FDA approval · 2012-07-17FDA Approved: ATORVASTATIN CALCIUM — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories' atorvastatin calcium as an original ANDA, enabling a generic atorvastatin calcium product.
-
FDA approval · 2012-07-12FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Quallent)
FDA approved a supplemental application for pravastatin sodium (Quallent), resulting in an approved change to the generic product.
-
FDA approval · 2012-07-09FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for WELCHOL (colesevelam hydrochloride) from Cosette Pharmaceuticals. The approval updates labeling …
-
FDA approval · 2012-06-12FDA Approved: FLUVASTATIN — Original Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's generic fluvastatin as an original application, enabling marketing of a generic statin product.
-
FDA approval · 2012-05-03FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Pravastatin Sodium from Aurobindo Pharma Limited, confirming continued approval of this generic …
-
FDA approval · 2012-03-02FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC, completing the changes described in the supplemental …
-
FDA approval · 2012-01-17FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Sun Pharmaceutical Industries Inc.)
FDA approved a supplemental application for atorvastatin calcium from Sun Pharmaceutical Industries Inc., enabling the generic atorvastatin …
-
FDA approval · 2012-01-11FDA Approved: SIMVASTATIN — Supplemental Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare, Inc.'s supplemental application for simvastatin (ANDA 078155).
-
FDA approval · 2012-01-09FDA Approved: SIMVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for simvastatin from Lupin Pharmaceuticals, Inc.
-
FDA approval · 2011-09-16FDA Approved: SIMVASTATIN — Original Application (Micro Labs Limited)
FDA approves Micro Labs Limited's original ANDA for simvastatin, a generic statin, enabling broader generic access in the U.S.
-
FDA approval · 2011-02-22FDA Approved: SIMVASTATIN — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Accord Healthcare's generic simvastatin (SIMVASTATIN), enabling its marketing as a generic stati…
-
FDA approval · 2010-09-18FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC under ANDA077691. This action pertains to the appr…
-
FDA approval · 2010-09-08FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC. The approval indicates an approved modification to th…
-
FDA approval · 2009-07-21FDA Approved: ZETIA — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Zetia (ezetimibe) submitted by Organon LLC.
-
FDA approval · 2009-03-27FDA Approved: LIPITOR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Lipitor (atorvastatin calcium) submitted by Viatris Specialty LLC.
-
FDA approval · 2008-11-06FDA Approved: CRESTOR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for CRESTOR (rosuvastatin) from AstraZeneca Pharmaceuticals LP. The approval updates the labeling to…
-
FDA approval · 2008-06-13FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) from Organon LLC.